(+49) 381 494-5066
Institute of Experimental Gene Therapy and Cancer Research
Top-level tumour research in interdisciplinary areas.
A international team of interdisciplinary scientists.
Production of vectors systems for scientific use.
Teaching and internships for young scientists.
LncRNA-SLC16A1-AS1 induces metabolic reprogramming during bladder cancer progression as target and co-activator of E2F1.
Cancers (Basel). 2019 Dec 8;11(12).
RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer.
Int J Mol Sci. 2019 Dec 13;20(24).
Alteration of GABAergic Input Precedes Neurodegeneration of Cerebellar Purkinje Cells of NPC1-Deficient Mice.
26. June 2020
A manuscript on E2F1 and lncRNA SLC16A1-AS1 in press in Theranostics
23. October 2019
Health research: Land promotes further alliances
26. June 2019
Poster award for PhD student at IEGT